Phase 3 Asthma trials recruiting now

All Asthma trials, every phase

Other phases for Asthma

Phase 3 Asthma trials

• A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma
  NCT07372287 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
  NCT06664619 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 189 locations
• A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
  NCT07309614 · Phase: Phase 3 · Ages: 18 Years to 79 Years · Sex: All (male and female) · 5 locations
• A Study of CM310 in Subjects With Moderate to Severe Asthma
  NCT05761028 · Phase: Phase 2, Phase 3 · Ages: 12 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of Depemokimab in Participants of 6 to 11 Years of Age
  NCT07671001 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · 3 locations
• A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
  NCT07456033 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 17 locations
• A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
  NCT05757102 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 67 locations
• A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
  NCT05562466 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · 64 locations
• A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
  NCT05776927 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 19 locations
• A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
  NCT06471257 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 102 locations
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
  NCT07276724 · Phase: Phase 3 · Ages: 12 Years to 80 Years · Sex: All (male and female) · 96 locations
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
  NCT07359846 · Phase: Phase 3 · Ages: 12 Years to 80 Years · Sex: All (male and female) · 96 locations
• A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
  NCT06023589 · Phase: Phase 3 · Ages: 5 Years to 11 Years · Sex: All (male and female) · 147 locations
• A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
  NCT07098403 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Anti-Inflammatory Reliever South Africa
  NCT06429475 · Phase: Phase 3 · Ages: 6 Years to 18 Years · Sex: All (male and female) · 2 locations
• Azithromycin for Critical Asthma - Pediatrics
  NCT06223828 · Phase: Phase 2, Phase 3 · Ages: 3 Years to 17 Years · Sex: All (male and female) · 1 location
• Beclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthma
  NCT07768891 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
  NCT06837922 · Phase: Phase 3 · Ages: 12 Years to 75 Years · Sex: All (male and female) · 1 location
• Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
  NCT06979323 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 50 locations
• Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
  NCT04891237 · Phase: Phase 3 · Ages: 12 Years to 65 Years · Sex: All (male and female) · 32 locations
• Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
  NCT04435990 · Phase: Phase 3 · Ages: 12 Years to 65 Years · Sex: All (male and female) · 32 locations
• Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
  NCT04898283 · Phase: Phase 3 · Ages: 12 Years to 65 Years · Sex: All (male and female) · 27 locations
• Efficacy and Safety Study of 610 in Patients With Severe Asthma
  NCT06323213 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists
  NCT07546981 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
  NCT07348302 · Phase: Phase 3 · Ages: 12 Years to 65 Years · Sex: All (male and female) · 19 locations
• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
  NCT06307665 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 150 locations
• Expertise Asthma COPD Program with Digital Support
  NCT05831566 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
  NCT06560255 · Phase: Phase 3 · Ages: 18 Years to 45 Years · Sex: Female · 2 locations
• Magnesium Trial in Acute Asthma in Emergency Department
  NCT06785272 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 6 locations
• Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
  NCT07363642 · Phase: Phase 3 · Ages: 12 Years to 80 Years · Sex: All (male and female) · 75 locations
• Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
  NCT06750289 · Phase: Phase 3 · Ages: 12 Years to 75 Years · Sex: All (male and female) · 160 locations
• Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
  NCT07444567 · Phase: Phase 3 · Ages: 6 Years and older · Sex: All (male and female) · 45 locations
• SIM0718 Treatment of Asthma Clinical Study
  NCT06488755 · Phase: Phase 3 · Ages: 12 Years to 75 Years · Sex: All (male and female) · 1 location
• Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma
  NCT07168473 · Phase: Phase 3 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
  NCT06829784 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 101 locations
• VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
  NCT06570889 · Phase: Phase 3 · Ages: 18 Years to 45 Years · Sex: Female · 2 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.